Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study

Lapatinib is used for the treatment of metastatic HER2(+) breast cancer. We aim to establish a prediction model for lapatinib dose using machine learning and deep learning techniques based on a real-world study. There were 149 breast cancer patients enrolled from July 2016 to June 2017 at Fudan Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ze, Ye, Xuan, Liu, Hongyue, Li, Huan, Hao, Xin, Zhang, Jinyuan, Kou, Fang, Wang, Zeyuan, Wei, Hai, Gao, Fei, Zhai, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203846/
https://www.ncbi.nlm.nih.gov/pubmed/35719963
http://dx.doi.org/10.3389/fonc.2022.893966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203846/
https://www.ncbi.nlm.nih.gov/pubmed/35719963
http://dx.doi.org/10.3389/fonc.2022.893966

Ejemplares similares